METAP2 and malaria: Fumagillin (Figure 1) and its synthetic analogs thereby irreversibly inhibit the methionine aminopeptidase-2 (MetAP2), making them promising therapeutic candidates against malaria parasites, trypanosomes, or other amoebae (Arico-Muendel et al., 2009).